Pharmacokinetics examines how the drug is absorbed, distributed, metabolized, and excreted by the body
According to standard clinical guidance and Omzo's own eligibility framing, licensed clinicians evaluating GLP-1 candidacy typically consider factors like body mass index, medical history, existing conditions (particularly thyroid disease, pancreatitis, or other contraindications for GLP-1 medications), current medications, and personal health goals
These regulatory distinctions can directly affect safety expectations, prescribing rules, and access pathways, and should be discussed with a licensed healthcare provider
However, severe pancreatitis, uncontrolled gallbladder disease, or signs of thyroid tumors require medical evaluation before starting
Smaller doses (0.25 mg, 0.5 mg, and 1 mg) cost $349 a month for existing patients